Text Size
3168 studies found for:    Open Studies | "Endocrine System Diseases"

Modify this search | How to Use Search Results

Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Cancel
Rank Status Study
1 Recruiting Aldosterone and the Metabolic Syndrome
Conditions: Metabolic Diseases;   Diabetes Mellitus;   Endocrine System Diseases;   Glucose Metabolism Disorders
Interventions: Drug: Renin-Angiotensin-Aldosterone System (RAAS) Activation;   Drug: Administration of Aliskiren, Spironolactone, or Placebo;   Drug: Increased Dose, Combination, or Placebo
2 Not yet recruiting Closing the Loop in Children and Adolescents With Type 1 Diabetes in the Home Setting
Conditions: Diabetes Mellitus;   Diabetes Mellitus, Type 1;   Glucose Metabolism Disorders;   Endocrine System Diseases;   Autoimmune Diseases
Interventions: Device: Overnight closed-loop;   Device: Real-time CGM alone
3 Recruiting Effect of L-Thyroxine on Lipid Profiles and Atherosclerosis in Subclinical Hypothyroidism
Conditions: Hypothyroidism;   Thyroid Diseases;   Endocrine System Diseases
Intervention: Drug: L-thyroxine
4 Not yet recruiting Effects of L-thyroxine Replacement on Serum Lipid and Atherosclerosis in Hypothyroidism
Conditions: Hypothyroidism;   Thyroid Diseases;   Endocrine System Diseases
Intervention: Drug: L-thyroxine
5 Recruiting Doxycycline Treatment in Graves' Orbitopathy
Conditions: Graves Ophthalmopathy;   Graves Disease;   Eye Diseases;   Thyroid Diseases;   Endocrine System Diseases;   Eye Diseases, Hereditary;   Hyperthyroidism;   Autoimmune Diseases;   Immune System Diseases
Intervention: Drug: Doxycycline
6 Recruiting Inherited Reproductive Disorders
Conditions: Endocrine Diseases;   Genetic Disorder;   Infertility;   Hypogonadism;   Amenorrhea
Intervention:
7 Recruiting Endocrine Studies in Health and Disease
Condition: Endocrine Diseases
Intervention:
8 Recruiting Asian Diabetes Surgery Study (ADSS): Clinical Predictor for the Success of Metabolic Surgery
Conditions: Disease;   Endocrine System Disease;   Diabetes Mellitus
Intervention:
9 Recruiting Pilot Study to Characterize and Examine the Pharmacokinetics and Efficacy of Chronocort® in Adults With CAH
Conditions: Endocrine Disease;   Adrenal Insufficiency;   Congenital Adrenal Hyperplasia
Intervention: Drug: Hydrocortisone Modified Release Capsules
10 Recruiting Mifepristone for Metabolic Syndrome
Conditions: Endocrine Disease;   Diabetes
Intervention: Drug: Mifepristone
11 Recruiting Evaluation of Women With Endocrine and Reproductive-Related Conditions
Conditions: Endocrine Disease;   Infertility
Intervention:
12 Recruiting Tissue Procurement for Biomedical Research
Conditions: Cardiovascular Diseases;   Cancer;   Endocrine Diseases;   Neurological Disorders;   Arthritis;   Mental Disorders
Intervention:
13 Recruiting Evaluation of Patients With Endocrine-Related Conditions
Conditions: Endocrine Disease;   Glucose Intolerance;   Hyperinsulinemia;   Impaired Glucose Tolerance;   Non Insulin Dependent Diabetes Mellitus;   Obesity;   Type II Diabetes Mellitus
Intervention:
14 Recruiting Hormonal Regulation of Puberty and Fertility
Conditions: Endocrine Disease;   Infertility;   Hypogonadism;   Amenorrhea;   Adolescents
Intervention:
15 Recruiting An Investigation of Pituitary Tumors and Related Hypothalmic Disorders
Conditions: Abnormalities;   Craniopharyngioma;   Cushing's Syndrome;   Endocrine Disease;   Pituitary Neoplasm
Intervention:
16 Recruiting Brain Imaging of Childhood Onset Psychiatric Disorders, Endocrine Disorders and Healthy Children
Conditions: Autoimmune Disease;   Congenital Adrenal Hyperplasia;   Healthy;   Mental Disorder Diagnosed in Childhood;   Neurologic Manifestations
Intervention:
17 Not yet recruiting One Week Comparison Study of PTH and PTHrP Infusions
Conditions: Osteoporosis;   Hypercalcemia of Malignancy;   Hyperparathyroidism;   Bone Diseases, Endocrine
Interventions: Drug: Parathyroid Hormone-related Protein (1-36);   Drug: parathyroid hormone (1-34);   Drug: PTH (1-34) and PTHrP (1-36)
18 Recruiting A Study of the Safety and Efficacy of MK-3102 in ≥18 and <45 Year-Old Subjects With Type 2 Diabetes Mellitus and Inadequate Glycemic Control (MK-3102-028 AM1)
Condition: Diabetes Mellitus
Interventions: Drug: MK-3102;   Drug: Placebo to MK-3102;   Drug: Metformin
19 Recruiting Effects of Alogliptin on Pancreatic Beta Cell Function
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: Alogliptin;   Drug: Metformin 750 mg
20 Recruiting Predictive Biomarkers of Response to Sunitinib in the Treatment of Poorly-differentiated NEURO-Endocrine Tumors
Conditions: Neuroendocrine Tumors;   Pancreatic Neoplasms;   Advanced Disease;   Sunitinib
Intervention: Drug: Sutent
To Top

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
† Indicates status has not been verified in more than two years